ED vs OGEN · P/E 18, rev $15.26B vs rev $37.7K
Consolidated Edison Inc (ED) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
ED currently screens at market cap $36.02B and trailing P/E 18.3. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the ED and OGEN stock pages for the full models.
Not investment advice.